http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070031902-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00 |
| filingDate | 2005-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20070031902-A |
| titleOfInvention | Identification and characterization of a subset of glioblastomas sensitive to treatment with imatinib |
| abstract | The present invention provides methods for diagnosing a cell proliferative disease in mammals in vitro using provided genetic labels, predicting behavior of a mammal suffering from cell proliferative disease in response to medical treatment with one or more PDGF receptor antagonists. And a method of selecting a mammal that is expected to respond to medical treatment with one or more PDGF receptor antagonists while suffering from a cell proliferative disease. |
| priorityDate | 2004-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 117.